Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
0.6700
Dollar change
-0.0228
Percentage change
-3.29
%
Index- P/E- EPS (ttm)-4.08 Insider Own- Shs Outstand3.98M Perf Week-11.66%
Market Cap2.67M Forward P/E- EPS next Y-1.22 Insider Trans- Shs Float1.12M Perf Month27.41%
Income-8.75M PEG- EPS next Q-0.47 Inst Own5.90% Short Float1.71% Perf Quarter25.69%
Sales0.00M P/S- EPS this Y78.27% Inst Trans25.82% Short Ratio0.01 Perf Half Y-13.29%
Book/sh1.08 P/B0.62 EPS next Y42.00% ROA-66.14% Short Interest0.02M Perf Year-84.86%
Cash/sh2.59 P/C0.26 EPS next 5Y- ROE-136.11% 52W Range0.48 - 6.18 Perf YTD-86.34%
Dividend Est.- P/FCF- EPS past 5Y67.35% ROI-116.99% 52W High-89.16% Beta1.84
Dividend TTM- Quick Ratio3.35 Sales past 5Y0.00% Gross Margin- 52W Low40.40% ATR (14)0.11
Dividend Ex-Date- Current Ratio3.02 EPS Y/Y TTM64.50% Oper. Margin0.00% RSI (14)47.02 Volatility8.74% 22.87%
Employees4 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price6.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q76.01% Payout- Rel Volume0.06 Prev Close0.69
Sales Surprise- EPS Surprise-6.82% Sales Q/Q- EarningsNov 07 BMO Avg Volume2.57M Price0.67
SMA20-10.45% SMA502.55% SMA200-33.83% Trades Volume150,394 Change-3.29%
Nov-07-24 08:00AM
Nov-05-24 08:00AM
Oct-31-24 04:05PM
Oct-22-24 08:00AM
Sep-09-24 08:30AM
08:30AM Loading…
Aug-08-24 08:30AM
Aug-06-24 05:00AM
Aug-01-24 04:10PM
Jun-27-24 08:00AM
Jun-25-24 04:05PM
Jun-12-24 08:00AM
May-09-24 08:30AM
May-02-24 04:10PM
Mar-15-24 10:52AM
Mar-13-24 04:05PM
04:05PM Loading…
Mar-07-24 04:05PM
Mar-05-24 08:34AM
08:00AM
Mar-04-24 08:00AM
Feb-14-24 09:00AM
Feb-08-24 08:00AM
Dec-13-23 08:30AM
Nov-10-23 12:19PM
Nov-08-23 05:46PM
Nov-03-23 08:41AM
Oct-24-23 09:32AM
08:28AM
Oct-02-23 12:25PM
Aug-09-23 08:30AM
Aug-02-23 04:45PM
08:00AM Loading…
Jul-27-23 08:00AM
May-24-23 08:15AM
May-08-23 05:00PM
May-02-23 08:30AM
Mar-22-23 09:13AM
Mar-21-23 08:30AM
Mar-11-23 02:59AM
Mar-08-23 05:08PM
Mar-02-23 04:05PM
Mar-01-23 08:30AM
Feb-22-23 08:39AM
Dec-13-22 08:30AM
Dec-05-22 11:15AM
Nov-10-22 08:30AM
Nov-03-22 07:00AM
Nov-01-22 08:30AM
Oct-18-22 08:30AM
Sep-13-22 08:30AM
Aug-23-22 01:43PM
Aug-18-22 07:00AM
Aug-11-22 04:30PM
Aug-09-22 04:23PM
Aug-05-22 09:28AM
Jul-28-22 08:30AM
Jul-18-22 11:43AM
Jul-15-22 08:30AM
07:30AM
Jul-06-22 08:30AM
Jun-15-22 04:01PM
08:30AM
Jun-14-22 08:30AM
Jun-10-22 10:23AM
Jun-06-22 11:22AM
08:00AM
May-23-22 08:30AM
May-17-22 08:30AM
May-11-22 11:24AM
Apr-25-22 01:05PM
08:30AM
Mar-24-22 08:30AM
Mar-15-22 08:41AM
Mar-10-22 08:00AM
Mar-01-22 08:00AM
Feb-17-22 08:00AM
Feb-10-22 08:00AM
Feb-08-22 08:30AM
Jan-26-22 08:00AM
Jan-24-22 07:15AM
Dec-15-21 09:00AM
Dec-14-21 08:30AM
Nov-16-21 08:30AM
Nov-11-21 08:30AM
Nov-08-21 08:00AM
Nov-04-21 09:25AM
Nov-02-21 08:30AM
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dunn GordonChief Financial OfficerSep 10 '24Buy0.8120,00016,20028,856Sep 11 04:30 PM
Dunn GordonChief Financial OfficerSep 09 '24Buy0.798,8567,0058,856Sep 11 04:30 PM
Carter Denise P.Chief Operating OfficerSep 04 '24Buy0.7831,81324,91247,092Sep 05 12:06 PM
Carter Denise P.Chief Operating OfficerSep 03 '24Buy0.655,9223,82515,279Sep 05 12:06 PM
Myers MichaelChief Executive OfficerSep 04 '24Buy0.7737,09428,42147,252Sep 05 12:03 PM
Myers MichaelChief Executive OfficerSep 03 '24Buy0.6280049510,158Sep 05 12:03 PM
LANGER DENNISDirectorJun 07 '24Sale0.7329721753Jun 10 04:10 PM